Cohance Lifesciences Ltd (COHANCE)

Cohance Lifesciences Ltd (COHANCE) is listed on the NSE in the Pharmaceuticals sector, Pharmaceuticals & Biotechnology industry. Market capitalisation: 16259.10 Cr. Figures below are as reported and are shown with their source and date.

Educational use only — GoQuant is a research tool. This page lists company facts only and is not a recommendation. Investment advice is provided by FINOME TECHNOLOGIES PVT LTD (AltQube), SEBI-registered Investment Adviser, registration no. INA000018373, under a signed advisory agreement and after a risk profile. Past performance is not indicative of future results.

Company profile

Sector
Pharmaceuticals
Industry
Pharmaceuticals & Biotechnology
Market cap (₹ Cr)
16,259.1

Suven Pharmaceuticals Ltd. manufactures chemical products. The company is headquartered in Hyderabad, Telangana. The company went IPO on 2020-03-09. The firm operates through Pharmaceuticals Manufacturing and Services segment. Its geographical segments include India, the United States, Europe and Rest of the World. In India, the Company sells bulk drugs and intermediates, fine chemicals and services. In the United States, the Company sells intermediates and services. In Europe, the Company sells bulk drugs and intermediates. In Rest of the World, the Company sells bulk drugs, intermediates and services. The Company’s wholly owned subsidiary is Suven Pharma Inc.

Source: finedge · as of 2026-09-29

Price, last year

Last close (₹): 453.85

Source: quantro_screener_metrics_job · as of 2026-10-22

Key figures

P/E
96.98
52-week high
917.85
52-week low
266.7
Revenue CAGR, 3 years (%)
19.17
Revenue CAGR, 5 years (%)
17.57
EPS CAGR, 3 years (%)
-33.84
EPS CAGR, 5 years (%)
-19.94

Source: quantro_screener_metrics_job · as of 2026-10-23

Annual summary

Year endedRevenue (₹ Cr)PAT (₹ Cr)EPS (₹)
Mar 20262,268.55179.234.68
Mar 20251,197.58267.8710.52
Mar 20241,051.35300.2811.8
Mar 20231,340.33411.2916.16
Mar 20221,320.22453.817.83

Source: finedge · as of 2026-07-21

Shareholding and promoter pledge

Promoter
57.49%
FII
5.59%
DII
21.79%
Public
15.12%
Promoter shares pledged
0%

Source: finedge · as of 2026-03-31

Similar companies

Source: quantro_company_profiles · as of 2026-10-23

Frequently asked questions

What does Cohance Lifesciences Ltd do?
Suven Pharmaceuticals Ltd. manufactures chemical products. The company is headquartered in Hyderabad, Telangana. The company went IPO on 2020-03-09. The firm operates through Pharmaceuticals Manufacturing and Services segment. Its geographical segments include India, the United States, Europe and Rest of the World. In India, the Company sells bulk drugs and intermediates, fine chemicals and services. In the United States, the Company sells intermediates and services. In Europe, the Company sells bulk drugs and intermediates. In Rest of the World, the Company sells bulk drugs, intermediates and services. The Company’s wholly owned subsidiary is Suven Pharma Inc.
Which sector is Cohance Lifesciences Ltd in?
Cohance Lifesciences Ltd is in the Pharmaceuticals sector, Pharmaceuticals & Biotechnology industry.
What are Cohance Lifesciences Ltd's latest annual revenue and profit?
For the year ended Mar 2026: revenue 2268.55 Cr, profit after tax 179.23 Cr.
What is the promoter holding and pledge in Cohance Lifesciences Ltd?
Promoter holding is 57.49%; pledged shares are 0.00% of the promoter holding.
Which companies are similar to Cohance Lifesciences Ltd?
Companies in the same sector of similar size: Natco Pharma Ltd, Jubilant Pharmova Ltd, Concord Biotech Ltd, Caplin Point Laboratories Ltd, Onesource Specialty Pharma Ltd, Eris Lifesciences Ltd.
Want more history and detail? Create a free account for the full price history, quarterly statements, balance sheet and cash flow.

Figures computed 2026-10-23.